Details for Patent: 10,792,271

Which drugs does patent 10,792,271 protect, and when does it expire?

Patent 10,792,271 protects IHEEZO and is included in one NDA.

This patent has twenty-three patent family members in twenty-two countries.

Summary for Patent: 10,792,271

Title:	Topical formulations of chloroprocaine and methods of using same
Abstract:	Topical dosages and formulations of chloroprocaine and pharmaceutically acceptable salts thereof are provided that are efficacious, chemically stable and physiologically balanced for safety and efficacy, particularly during ophthalmic procedures or in response to ophthalmic abrasions or trauma.
Inventor(s):	Augusto Mitidieri, Elisabetta Donati, Clara Bianchi
Assignee:	Sintetica SA
Application Number:	US16/131,174
Patent Claim Types: see list of patent claims	Use; Formulation;

Drugs Protected by US Patent 10,792,271

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Harrow Eye	IHEEZO	chloroprocaine hydrochloride	GEL;OPHTHALMIC	216227-001	Sep 27, 2022		RX	Yes	Yes	10,792,271		Y			METHOD OF INDUCING OCULAR ANESTHESIA

International Family Members for US Patent 10,792,271

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2018332212
Brazil	112020003095
Canada	3070336
Chile	2020000665